Horizon Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Buy
1,359
+371
+38% +$379K 0.63% 32
2026
Q1
$909K Buy
988
+59
+6% +$59.8K 0.4% 40
2025
Q4
$998K Buy
929
+8
+0.9% +$7.65K 0.45% 38
2025
Q3
$703K Buy
921
+30
+3% +$22.3K 0.34% 42
2025
Q2
$695K Hold
891
0.37% 42
2025
Q1
$736K Buy
891
+1
+0.1% +$832 0.41% 41
2024
Q4
$687K Hold
890
0.39% 39
2024
Q3
$788K Hold
890
0.47% 35
2024
Q2
$806K Hold
890
0.51% 34
2024
Q1
$692K Buy
+890
New +$633K 0.44% 35

Other funds holding LLY

Horizon Financial Services's LLY Position: Q2 2026 in Review

Horizon Financial Services increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $379K and bringing the position to 1,359 shares worth $1.63M. The position accounts for 0.63% of the portfolio, ranked #32.

Horizon Financial Services first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Horizon Financial Services held 1,359 shares of Eli Lilly worth $1.63M as of Q2 2026.
  • Horizon Financial Services bought 371 Eli Lilly shares in Q2 2026, an estimated $379K.
  • Eli Lilly made up 0.63% of Horizon Financial Services's portfolio in Q2 2026, its #32 holding.
  • Horizon Financial Services first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Horizon Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.